Egis Gyogyszergyar

Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.

Basfaktiengesellschaft

Alkaloida Vegyeszeti Gyar

Biogal Gyogyszergyar

Andras Varro

Gyorgy Rabloczky

Istvan Elekes

Laszlo Jaszlits

Maria Kuhar Nee Kurthy

Gyorgy Cseh

Sandor Elek

Peter Matyus

Ilona Bodi

Imre Moravcsik

Marton Fekete

Gyula Horvath

Tamas Hamori

Lajos Toldy

Endre Kasztreiner

Jeno Korosi

Tibor Lang

Zoltan Zubovics

Peter Botka

Katalin Szemeredi

Gabor Zolyomi

Jozsef Borsi

Geza Szilagyi

Istvan Ling

Laszlo Sebestyen

Nandor Makk

Agnes Papp

Zsuzsanna Lang Nee Rihmer

Erzsebet Zara

Eva Bozo

Ferene Andrasi

Eszter Diesler

Judit Sarossy Nee Kincsesy

Ildiko Varga

Gyongyi Nagy Nee Csokas

Klara Czako

Aniko Tegdes

ZSuzanne Lang Nee Rihmer

Laszlo Szatmary

Laszlo Czollner

Jeno Marosfalvi

Istvan Erczi

Sarolta Vegvari Nee Gyurki

Laszlo Szam

Judit Sarossy Nee Kincsessy

Luca Levay

Gvorgy Schmidt

Aniko Miklos

Andrea Jednakovics

Racemic or optically active new 3(2H)-pyridazinone derivatives, a process for the preparation thereof, pharmaceutical compositions comprising the same, to the use of the said 3(2H)-pyridazinone derivatives for the treatment of diseases and for the preparation of pharmaceutical compositions suitable for the treatment of diseases. The new 3(2H)-pyridazinone derivatives according to the invention correspond to the general formula (I), ##STR1##

3(2H)-pyridazinone derivatives and process for the preparation thereof

The invention is directed to 1-(2,6-Dimethyl-Phenyl-amino)-2-Dimethyl-amino-Propane and the pharmaceutical composition thereof useful for the treatment of cardiac rhythm disorders.

New alkylene diamine derivatives

The invention relates to new substituted dihydropyridine derivatives of the general formula (I), ##STR1## wherein R.sup.1 and R.sup.6 are as defined herein after, the racemic and optically active variants as well as mixtures thereof, furthermore the acid addition salts of these compounds, pharmaceutical compositions containing the same and a process for the preparation thereof. The compounds of the general formula (I) can be advantageously applied for the treatment of pathologically severe hypertensions, their toxicity is low and they possess an advantageous therapeutic index.

Novel dihydropyridines having calcium antagonistic and antihypertensive

This invention relates to new 3-(hydroxymethyl)-isoquinoline derivatives of the general formula (I), their acid addition salts, and to a process for the preparation thereof, furthermore to pharmaceutical compositions containing the same, ##STR1## wherein R and R.sup.1 are identical or different and stand for a hydrogen or halogen atom, a nitro or a C.sub.1-4 alkoxy group,

3-(hydroxymethyl)-isoquinoline derivatives

The invention relates to novel pyrimido [5,4-b][1,4]oxazine derivatives of the formula (I), and the acid addition salts thereof, pharmaceutical compositions containing them and a process for their preparation. In the formula (I) ##STR1## wherein R.sup.1 stands for a C.sub.1-4 alkyl group;

Pyrimido[5,4-B][1,4]oxazine derivatives and pharmaceutical compositions

The invention relates to new aminoguanidine derivatives of the general formula (I), ##STR1## wherein R.sup.1, R.sup.2 and R.sup.3 each represent hydrogen or halogen atom, C.sub.1-4 alkyl, nitro, trifluoromethyl or C.sub.1-4 alkoxy group,

Aminoguanidine compounds, their compositions and pharmaceutical uses

Growing community of inventors

Budapest, Hungary

Andras Varro